Cardiac Marker Diagnostic Testing Markets Published by TriMark Publications in November 2011
The purpose of this TriMark Publications report is to describe the specific market segment of the in vitro diagnostics (IVD) market devoted to cardiac marker testing. This study examines clinical measurement devices and their reagents and supplies as used in hospitals, ...(more)
The Outlook for Pharmaceuticals in Western Europe Published by Espicom in November 2011
Market growth in the mature markets of Western Europe is assured over the coming years by the health needs of ageing populations, and will be driven by investment in innovative medicines, particularly in the hospital market. Growth, however, will be tempered somewhat by...(more)
The Outlook for Pharmaceuticals in South East Asia Published by Espicom in November 2011
Detailed analysis of four pharmaceutical markets that present immense potential for pharmaceutical manufacturers. China and Japan will be the largest and second largest pharmaceutical markets in the Asia Pacific region covered by Espicom in 2016.
Diverse markets, diver...(more)
E7: The Outlook for Pharmaceuticals to 2012 Published by Espicom in November 2011
The E7 economies represent increasing opportunities for pharmaceutical companies constrained by maturing markets in the west.
Huge potential in E7 markets
The emerging E7 countries represent the best prospect for growth. The potential of these countries is huge: they...(more)
The Outlook for Pharmaceuticals in Latin America Published by Espicom in November 2011
Strong pharmaceutical market growth opportunities and regulatory developments are making Latin America more attractive
The region needs to increase drug access, in spite of intensifying cost-containment measures. Therefore, attractive opportunities for (bio)pharmaceut...(more)
The Outlook for Pharmaceuticals in Central Asia Published by Espicom in November 2011
These leading emerging economies represent a combined pharmaceutical market of US$132.2 billion. How have they emerged from the economic downturn? Where do commercial opportunities exist for pharmaceutical companies over the 2011-16 forecast period?These reports provide...(more)
The Outlook for Pharmaceuticals in Central & Eastern Europe Published by Espicom in November 2011
The pharmaceutical market of Central & Eastern Europe is estimated at US$63.6 billion at retail prices in 2011; it is expected to reach US$104.2 billion by 2016. The market is expected to expand by a moderate CAGR in US dollar terms between 2011 and 2016, as the reg...(more)
The Outlook for Pharmaceuticals in Brazil, Russia, India & China Published by Espicom in November 2011
These leading emerging economies represent a combined pharmaceutical market of US$132.2 billion. How have they emerged from the economic downturn? Where do commercial opportunities exist for pharmaceutical companies over the 2011-16 forecast period?Putting things in per...(more)
The Outlook for Pharmaceuticals in the Middle East and North Africa Published by Espicom in November 2011
Attractive macro-environmental conditionsIn spite of recent political unrest, economic, social and demographic changes are making the pharmaceutical markets in the Middle East & North Africa (MENA) region more attractive. The Economist Intelligence Unit (EIU) foreca...(more)
The Outlook for Pharmaceuticals in North East Asia Published by Espicom in November 2011
Detailed analysis of four pharmaceutical markets that present immense potential for pharmaceutical manufacturers. China and Japan will be the largest and second largest pharmaceutical markets in the Asia Pacific region covered by Espicom in 2016.
Diverse markets, diver...(more)
Registered Office: 2a Altons House Office Park, Gatehouse Way, Aylesbury, HP19 3XU, UK
Registered in England and Wales No. 3240740 VAT No. GB 685 4343 10
CMSInfo (Chiltern Magazine Services Ltd.) is a company registered at Companies House in England and Wales (Company No. 3240740). CMSInfo is also registered in accordance with the Data Protection Act 1998 (registration number R0094104).
